{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:19:51Z","timestamp":1791181191843,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1136\/ard.2009.118406","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T00:31:51Z","timestamp":1273105911000},"page":"1029-1035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment"],"prefix":"10.1016","volume":"69","author":[{"given":"Rachael J L","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimme L","family":"Hyrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann W","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony G","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2009.118406_bib1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/rheumatology\/41.7.793","article-title":"The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century","volume":"41","author":"Symmons","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.118406_bib2","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2009.118406_bib3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2217\/14622416.8.7.761","article-title":"Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis","volume":"8","author":"Coenen","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1136\/ard.2009.118406_bib4","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/rheumatology\/kel149","article-title":"Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register","volume":"45","author":"Hyrich","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2009.118406_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/ard.2007.084715","article-title":"Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis","volume":"68","author":"Potter","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2009.118406_bib6","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.2337\/db07-0440","article-title":"Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study","volume":"56","author":"Pearson","year":"2007","journal-title":"Diabetes"},{"key":"10.1136\/ard.2009.118406_bib7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ng.233","article-title":"Common variants at CD40 and other loci confer risk of rheumatoid arthritis","volume":"40","author":"Raychaudhuri","year":"2008","journal-title":"Nat Genet"},{"key":"10.1136\/ard.2009.118406_bib8","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/ng.2007.32","article-title":"Rheumatoid arthritis association at 6q23","volume":"39","author":"Thomson","year":"2007","journal-title":"Nat Genet"},{"key":"10.1136\/ard.2009.118406_bib9","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/ng.2007.27","article-title":"Two independent alleles at 6q23 associated with risk of rheumatoid arthritis","volume":"39","author":"Plenge","year":"2007","journal-title":"Nat Genet"},{"key":"10.1136\/ard.2009.118406_bib10","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa073003","article-title":"STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus","volume":"357","author":"Remmers","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2009.118406_bib11","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1093\/hmg\/ddn128","article-title":"Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility","volume":"17","author":"Barton","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1136\/ard.2009.118406_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2119\/2007-00072.Lee","article-title":"Association of STAT4 with rheumatoid arthritis in the Korean population","volume":"13","author":"Lee","year":"2007","journal-title":"Mol Med"},{"key":"10.1136\/ard.2009.118406_bib13","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa073491","article-title":"TRAF1-C5 as a risk locus for rheumatoid arthritis \u2013 a genomewide study","volume":"357","author":"Plenge","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2009.118406_bib14","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1086\/522037","article-title":"Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases","volume":"81","author":"Zhernakova","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ard.2009.118406_bib15","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/hmg\/ddp177","article-title":"Identification of AF4\/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes","volume":"18","author":"Barton","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1136\/ard.2009.118406_bib16","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/ng.218","article-title":"Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13","volume":"40","author":"Barton","year":"2008","journal-title":"Nat Genet"},{"key":"10.1136\/ard.2009.118406_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/gene.2008.82","article-title":"CD226 Gly307Ser association with multiple autoimmune diseases","volume":"10","author":"Hafler","year":"2009","journal-title":"Genes Immun"},{"key":"10.1136\/ard.2009.118406_bib18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1136\/ard.2009.118406_bib19","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/bioinformatics\/btn564","article-title":"SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap","volume":"24","author":"Johnson","year":"2008","journal-title":"Bioinformatics"},{"issue":"Suppl 2","key":"10.1136\/ard.2009.118406_bib20","first-page":"3","article-title":"Insulin resistance and insulin sensitizers","volume":"55","author":"Stumvoll","year":"2001","journal-title":"Horm Res"},{"key":"10.1136\/ard.2009.118406_bib21","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1742-7843.2009.00375.x","article-title":"Abatacept, a novel CD80\/86-CD28 T cell co-stimulation modulator, in the treatment of rheumatoid arthritis","volume":"104","author":"Korhonen","year":"2009","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1136\/ard.2009.118406_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1182\/blood-2005-01-0341","article-title":"Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity","volume":"106","author":"Bodin","year":"2005","journal-title":"Blood"},{"key":"10.1136\/ard.2009.118406_bib23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/FPC.0b013e328328d51f","article-title":"Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patients","volume":"19","author":"Bowes","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1136\/ard.2009.118406_bib24","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1093\/hmg\/ddn245","article-title":"Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis","volume":"17","author":"Maxwell","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1136\/ard.2009.118406_bib25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa0809329","article-title":"Estimation of the warfarin dose with clinical and pharmacogenetic data","volume":"360","author":"Klein","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2009.118406_bib26","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1182\/blood-2008-01-134247","article-title":"A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose","volume":"112","author":"Cooper","year":"2008","journal-title":"Blood"},{"key":"10.1136\/ard.2009.118406_bib27","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1182\/blood.V87.2.734.bloodjournal872734","article-title":"LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias","volume":"87","author":"Ma","year":"1996","journal-title":"Blood"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724194587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724194587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2009.118406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T14:07:31Z","timestamp":1736086051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724194587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0003496724194587"],"URL":"https:\/\/doi.org\/10.1136\/ard.2009.118406","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2009.118406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}